EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The outcomes of valve-in-valve TMVR for patients with mitral bioprosthetic valve dysfunction: a single-center retrospective study

Tao Zhang, Yahua Li, Bin Lin, Li Li, Bowen Lian, Pengju Guo, Xiaoyan Zhao

Frontiers in Cardiovascular Medicine · 21.04.2026 · 13

DOI: 10.3389/fcvm.2026.1747077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 21.04.2026. Verfasst von Tao Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To explore the clinical efficacy and follow-up results of the valve-in-valve transcatheter mitral valve replacement (TMVR) technique in patients with mitral bioprosthetic valve dysfunction.

Methods

The medical data of patients with biological valve dysfunction after mitral valve replacement who underwent TMVR in our hospital from January 2019 to January 2024 were retrospectively collected. The echocardiography data, New York Heart Association (NYHA) grade, EuroQol visual analogue scale (EQ-VAS) score, and 6-minute walking distance before and after the operation were compared.

Results

A total of 33 patients, 8 males and 25 females, with an average age of 70.70 ± 9.04 years, were included in this study. All 33 patients underwent TMVR surgery successfully. Seven patients underwent surgery via the atrial septal approach, and 26 patients underwent surgery via the apical approach. The success rate of the TMVR was 100.0%. One patient had a complication of cerebral infarction and eventually died 7 days after the operation. Compared with those prior to the operation, the NYHA grade, EQ-VAS score and the 6-minute walking distance were improved significantly at follow-up (all P < 0.05).

Conclusion

Valve-in-valve TMVR is a feasible option for patients with degenerated bioprosthetic mitral valves. However, follow-up studies are still needed to determine the long-term effects.

Schlagwörter

Stichwörter der Autor:innen

TMVRbioprosthetic valve dysfunctiontransapicaltransseptalvalve-in-valve (VIV)

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Zitieren

APA

Zhang, T., Li, Y., Lin, B., Li, L., Lian, B., Guo, P., & Zhao, X. (2026). The outcomes of valve-in-valve TMVR for patients with mitral bioprosthetic valve dysfunction: a single-center retrospective study. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1747077

Vancouver

Zhang T, Li Y, Lin B, Li L, Lian B, Guo P, et al. The outcomes of valve-in-valve TMVR for patients with mitral bioprosthetic valve dysfunction: a single-center retrospective study. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1747077

BibTeX
@article{Zhang2026,
  author = {Zhang, Tao and Li, Yahua and Lin, Bin and Li, Li and Lian, Bowen and Guo, Pengju and Zhao, Xiaoyan},
  title = {The outcomes of valve-in-valve TMVR for patients with mitral bioprosthetic valve dysfunction: a single-center retrospective study},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1747077}
}
Kostenlos starten →